#ftgf
#carolinestrong
Nov 2017: Diagnosed with Stage IV high-risk Neuroblastoma. Nov 2017–Apr 2019: Completed standard treatment; NED. Apr 2019–Apr 2021: Completed DFMO clinical trial. Apr 2022: Relapse. Apr 2022–Jun 2023: Completed relapse treatment; NED again. Jun 2023–Jun 2024: High-dose DFMO (compassionate use) clinical trial. Jun 2024: Second relapse. Jul 2025: NED again. Mar 2026: Relapse.

A video message from Caroline:
Family Meals via UberEats Gift Cards (sent to margaretlantz@gmail.com)
#ftgf
#carolinestrong
PS - we've already had quite a few requests on how people can help in the meantime:
UberEats Gift Cards (sent to margaretlantz@gmail.com)
Caroline went to Vanderbilt today for the FINAL refill supply of her clinical trial drug, DFMO. The trial will end for her on April 17, 2021, at which time she will be completely medication-free! After two years of taking six DFMO pills each day, this is both exciting and terrifying for us.
In addition to getting the refill meds today, she received blood and urine tests; we are still waiting on those results and should have them sometime next week. Her next round of scans and tests are scheduled for mid-April, right before completing the clinical trial, so we will update the blog again at that time.
Right now, Caroline is excelling in first grade, taking acting classes, and just wrapped up her first-ever basketball season.